Clinical Trial Update: Trial of Cyclosporine in the Acute Phase of Leber Hereditary Optic Neuropathy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating cyclosporine in the acute phase of Leber hereditary optic neuropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leber Hereditary Optic Neuropathy

Drugs mentioned

• CYCLOSPORINE (cyclosporine)

Snippet

Sponsor: University Hospital, Angers | Conditions: Leber Hereditary Optic Neuropathy | Phase 2 | Status: UNKNOWN